In the News

Amesh Adalja and David Dowdy are quoted. 

Experts are split on whether the waning delta surge will be the last major COVID-19 wave to strike the U.S., as Americans grow eager for the pandemic to end after 19 months.

Pfizer is the first drug company to request emergency authorization use of its COVID-19 vaccine for children ages 5 to 11.

There’s a new campaign in Baltimore, using hip hop to build vaccine confidence in the city’s youth because Baltimore City is 20 percent below the state average on vaccinations for teens.
 

Experts say that steady inoculation rates are crucial to avoid a winter coronavirus surge. San Francisco is easing some mask restrictions for vaccinated people.
 

At some point, the pandemic emergency — both in its legal designation and its intense impact on daily life — will have to end. The U.S. is learning to live with an endemic virus, albeit one whose worst effects are blunted by the protection of vaccines and prior immunity.

Bill Moss and Anna Durbin are quoted. 

If you got a two-dose mRNA vaccine and you’re not currently eligible for a booster, you may never need that third dose.

One in five Americans now say they're anti-vaxxers. As resistance expands beyond COVID, health experts call the potential impact 'extremely concerning.'

Responses to most diseases don't fall along partisan lines, but COVID-19 has been an exception. Anti-vaccine sentiments used to be bipartisan but now are held mostly by Republicans.

As more companies implement COVID-19 vaccine mandates, you might be curious about medical exemptions.

The summer surge of U.S. coronavirus cases has started to ebb after exposing the grave danger the virus still poses in areas where large swaths of the population lack immunity.

A survey of Americans on President Joe Biden’s plan to require most workers to get either vaccinated or regularly tested for COVID-19 finds a deep and familiar divide: Democrats are overwhelmingly for it, while most Republicans are against it.

An avalanche of misinformation about the antiparasitic drug ivermectin’s ability to treat COVID-19 has caused a series of national problems, from increased calls to poisoning centers to a shortage of the medicine itself.